RenovoRx, Inc.

RNXT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$2,912-$2,895-$2,420-$2,878
Dep. & Amort.-$1$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$349$345$288$0
Change in WC$446-$123-$688-$142
Other Non-Cash-$152$370-$562$590
Operating Cash Flow-$2,270-$2,302-$3,381-$2,430
Investing Activities
PP&E Inv.$0$0-$2-$12
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$2-$12
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1,299$0$10,803$33
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1,299$34$8$0
Financing Cash Flow$0$34$10,811$33
Forex Effect$0$0$0$0
Net Chg. in Cash-$2,270-$2,268$7,428-$2,409
Supplemental Information
Beg. Cash$12,314$14,582$7,154$9,563
End Cash$10,044$12,314$14,582$7,154
Free Cash Flow-$2,270-$2,302-$3,383-$2,442